The relationship between IGF-2, IGFBP-2, and IGFBP-3 levels in patients suffering from pre-diabetes

H. Ismayilnajadteymurabadi, D. Konukoglu

Article ID: 5051
Vol 32, Issue 1, 2018
DOI: https://doi.org/10.54517/jbrha5051
Received: 11 March 2018; Accepted: 11 March 2018; Available online: 11 March 2018; Issue release: 11 March 2018

Abstract

Many studies have shown that intervention in the early stages of diabetes may have a pivotal role in reducing the risk of cardiovascular diseases. This study was designed to assess possible relationships between insulin-like growth factor 2 (IGF-2), insulin-like growth factor binding proteins 2 and 3 (IGFBP-2, IGFBP-3) and pre-diabetes. A total of sixty clinically ascertained pre-diabetes cases and twenty-five healthy controls were included. Serum IGF-2 and binding proteins were estimated using commercially available ELISA kit. All groups had a positive correlation between all serum parameters. Multinomial logistic regression showed that all the study parameters directly affected each other. The results could not prove any correlation between IGF-2 and its binding proteins during pre-diabetes stage. Further assessments of these factors in larger groups of males and females in diabetic individuals could be useful to support our hypothesis that these factors change only in diabetes mellitus


Keywords

prediabetes state;insulin-like growth factor 2;insulin-like growth factor-binding protein


References

Supporting Agencies



Copyright (c) 2018 H. Ismayilnajadteymurabadi, D. Konukoglu




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).